Bifidobacterium longum RAPO Attenuates Dermal and Pulmonary Fibrosis in a Mouse Model of Systemic Sclerosis through Macrophage Modulation and Growth of Short-Chain Fatty Acid Producers

키워드

참고문헌 (62)

1. Jeong JE, "Clinical characteristics of juvenile systemic sclerosis in Korea : 31-year single-center study", J Rheum Dis, 31, pp.25~32 (2024)
2. Tsou PS, "Advances in epigenetics in systemic sclerosis : molecular mechanisms and therapeutic potential", Nat Rev Rheumatol, 17, pp.596~607 (2021)
3. Bukiri H, "Current advances in the treatment of systemic sclerosis", Curr Opin Pharmacol, 64, pp.102211~ (2022)
4. Lee SG, "Epidemiology and treatment of systemic sclerosis in Korea", J Rheum Dis, 29, pp.200~214 (2022)
5. Volkmann ER, "Is there a role for the microbiome in systemic sclerosis?", Expert Rev Clin Immunol, 19, pp.237~240 (2023)
6. Volkmann ER, "Association of systemic sclerosis with a unique colonic microbial consortium", Arthritis Rheumatol, 68, pp.1483~1492 (2016)
7. Plichta DR, "Congruent microbiome signatures in fibrosis-prone autoimmune diseases : IgG4-related disease and systemic sclerosis", Genome Med, 13, pp.35~ (2021)
8. Mehta H, "Early-life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis", J Invest Dermatol, 137, pp.2316~2325 (2017)
9. Park HJ, "Butyrate improves skin", lung fibrosis and intestinal dysbiosis in bleomycin-induced mouse models, 2021, pp.22, 2765~
10. Strahm N, "Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis", Rheumatology(Oxford), 62, pp.2918~2929 (2023)
11. Marighela TF, "Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis : a randomized placebo-controlled trial", Rheumatology(Oxford), 58, pp.1985~1990 (2019)
12. Hoffmann-Vold AM, "Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome(ACHIM)in patients with systemic sclerosis : study protocol for the randomised controlled phase II ReSScue trial", BMJ Open, 11, pp.e048541~ (2021)
13. Balakrishnan B, "Prevotella histicola protects from arthritis by expansion of Allobaculum and augmenting butyrate production in humanized mice", Front Immunol, 12, pp.609644~ (2021)
14. Scher JU, "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis", Elife, 2, pp.e01202~ (2013)
15. Wensel CR, "Next-generation sequencing : insights to advance clinical investigations of the microbiome", J Clin Invest, 132, pp.e154944~ (2022)
16. Li J, "Development of a bacterial macroarray for the rapid screening of targeted antibody-secreted hybridomas", SLAS Discov, 24, pp.190~198 (2019)
17. Campanero-Rhodes MA, "Development and evaluation of a microarray platform for detection of serum antibodies against Streptococcus pneumoniae capsular polysaccharides", Anal Chem, 92, pp.7437~7443 (2020)
18. Lee SH, "Anti-microbial antibody response is associated with future onset of Crohn’s disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk", Gastroenterology, 161, pp.1540~1551 (2021)
19. Thirumalapura NR, "Bacterial cell microarrays for the detection and characterization of antibodies against surface antigens", J Immunol Methods, 309, pp.48~54 (2006)
20. Campanero-Rhodes MA, "Microarray strategies for exploring bacterial surface glycans and their interactions with glycan-binding proteins", Front Microbiol, 10, pp.2909~ (2020)
21. Kim S, "Peptoniphilus gorbachii alleviates collagen-induced arthritis in mice by improving intestinal homeostasis and immune regulation", Front Immunol, 14, pp.1286387~ (2024)
22. Hübner RH, "Standardized quantification of pulmonary fibrosis in histological samples", Biotechniques, 44, pp.507~517 (2008)
23. Rivière A, "Bifidobacteria and butyrate-producing colon bacteria : importance and strategies for their stimulation in the human gut", Front Microbiol, 7, pp.979~ (2016)
24. Mysore V, "Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2", J Exp Med, 219, pp.e20210562~ (2022)
25. Vujkovic-Cvijin I, "The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces", Sci Transl Med, 14, pp.eabl3927~ (2022)
26. Papp M, "Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?", PLoS One, 5, pp.e12957~ (2010)
27. Watanabe D, "Contribution of the gut microbiota to intestinal fibrosis in Crohn’s disease", Front Med(Lausanne), 9, pp.826240~ (2022)
28. Rieder F, "The gut microbiome in intestinal fibrosis : environmental protector or provocateur?", Sci Transl Med, 5, pp.190~ (2013)
29. Christmann BS, "Human seroreactivity to gut microbiota antigens", J Allergy Clin Immunol, 136, pp.1378~1386 (2015)
30. Zeng MY, "Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens", Immunity, 44, pp.647~658 (2016)
31. Fretheim H, "Fecal microbiota transplantation in systemic sclerosis : a double-blind, placebo-controlled randomized pilot trial", PLoS One, 15, pp.e0232739~ (2020)
32. Volkmann ER, "Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts", BMJ Open Gastroenterol, 4, pp.e000134~ (2017)
33. Natalello G, "Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status", Clin Exp Rheumatol, 38(Suppl 125), pp.73~84 (2020)
34. Arron ST, "High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis", J Invest Dermatol, 134, pp.2138~2145 (2014)
35. Johnson ME, "Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin", Arthritis Res Ther, 21, pp.49~ (2019)
36. Takahashi Y, "Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis", Respir Res, 19, pp.34~ (2018)
37. Nakajima A, "IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria", J Exp Med, 215, pp.2019~2034 (2018)
38. Magri G, "Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals", Immunity, 47, pp.118~134 (2017)
39. Boonstra M, "Association of anti–topoisomerase I antibodies of the IgM isotype with disease progression in anti–topoisomerase I–positive systemic sclerosis", Arthritis Rheumatol, 72, pp.1897~1904 (2020)
40. Jones K, "Immunoglobulin M in health and diseases : how far have we come and what next?", Front Immunol, 11, pp.595535~ (2020)
41. Sterlin D, "The antibody", microbiota interface in health and disease, 2020, pp.13, 3~11
42. Fang Z, "Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis", Gut Microbes, 14, pp.2044723~ (2022)
43. MacSharry J, "Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse", Pulm Pharmacol Ther, 25, pp.325~334 (2012)
44. Derrien M, "Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood", Trends Microbiol, 30, pp.940~947 (2022)
45. Devika NT, "Deciphering the metabolic capabilities of Bifidobacteria using genome-scale metabolic models", Sci Rep, 9, pp.18222~ (2019)
46. Oh DK, "Bifidobacterium longum BORI inhibits pain behavior and chondrocyte death, and attenuates osteoarthritis progression", PLoS One, 18, pp.e0286456~ (2023)
47. Jeong Y, "Therapeutic potential of a novel Bifidobacterium identified through microbiome profiling of RA patients with different RF levels", Front Immunol, 12, pp.736196~ (2021)
48. Ruiz L, "Bifidobacteria and their molecular communication with the immune system", Front Microbiol, 8, pp.2345~ (2017)
49. Gong P, "Mesenchymal stem cells alleviate systemic sclerosis by inhibiting the recruitment of pathogenic macrophages", Cell Death Dis, 8, pp.466~ (2022)
50. Toledo DM, "Macrophages in systemic sclerosis : novel insights and therapeutic implications", Curr Rheumatol Rep, 21, pp.31~ (2019)
51. Al-Adwi Y, "Macrophages as determinants and regulators of fibrosis in systemic sclerosis", Rheumatology(Oxford), 62, pp.535~545 (2023)
52. Mathes AL, "Global chemokine expression in systemic sclerosis(SSc) : CCL19 expression correlates with vascular inflammation in SSc skin", Ann Rheum Dis, 73, pp.1864~1872 (2014)
53. Wu M, "Ccl2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis : data from two independent cohorts", Arthritis Rheumatol, 69, pp.1871~1878 (2017)
54. Bhandari R, "Profibrotic activation of human macrophages in systemic sclerosis", Arthritis Rheumatol, 72, pp.1160~1169 (2020)
55. Flint HJ, "Links between diet, gut microbiota composition and gut metabolism", Proc Nutr Soc, 74, pp.13~22 (2015)
56. Lee C, "Microbial components and effector molecules in T helper cell differentiation and function", Immune Netw, 23, pp.e7~ (2023)
57. Li M, "Pro-and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells", Eur J Pharmacol, 831, pp.52~59 (2018)
58. He M, "Gut microbiota as a potential target of metabolic syndrome : the role of probiotics and prebiotics", Cell Biosci, 7, pp.54~ (2017)
59. Kou R, "Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against high-fat-diet-induced obesity and gut microbiota disorder", Nutrients, 15, pp.4104~ (2023)
60. Trompette A, "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis", Nat Med, 20, pp.159~166 (2014)
61. Bermudez-Brito M, "Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation", PLoS One, 8, pp.e59370~ (2013)
62. Yang KM, "Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria", Sci Rep, 11, pp.1631~ (2021)

관련 논문AI추천